| Q34495491 | A rabbit model of thrombosis on atherosclerotic lesions |
| Q37205659 | A serotonin-induced N-glycan switch regulates platelet aggregation |
| Q58481433 | Antiplatelet drugs |
| Q34775088 | Antithrombotic and antiplatelet activities of Soshiho-tang extract |
| Q28552988 | BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway |
| Q80769322 | Bilateral simultaneous central retinal artery occlusion following head injury |
| Q42171127 | Both 5-hydroxytryptamine 5-HT2A and 5-HT1B receptors are involved in the vasoconstrictor response to 5-HT in the human isolated internal thoracic artery |
| Q37786639 | Clopidogrel in acute coronary syndrome: implications of recent study findings |
| Q42687813 | Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate |
| Q37782412 | Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention |
| Q35892630 | Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin |
| Q48283354 | Doxepin inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation |
| Q34001485 | Effect of serotonin on platelet function in cocaine exposed blood |
| Q53257546 | Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers. |
| Q36679155 | Effects of the 5-HT2A Antagonist Sarpogrelate on Walking Ability in Patients with Intermittent Claudication as Measured Using the Walking Impairment Questionnaire |
| Q33435199 | Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo |
| Q34980796 | Impact of elevated plasma serotonin on global gene expression of murine megakaryocytes |
| Q47639140 | Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway |
| Q33684221 | Inhibition of platelet aggregation and thrombosis by indole alkaloids isolated from the edible insect Protaetia brevitarsis seulensis (Kolbe). |
| Q40006101 | Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans |
| Q44626515 | Sarpogrelate hydrochloride, a selective 5-HT(2A) receptor antagonist, improves skin perfusion pressure of the lower extremities in hemodialysis patients with peripheral arterial disease |
| Q34182816 | Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study |
| Q45961045 | Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. |
| Q46627647 | Serotonin induces vasoconstriction of smooth muscle cell-rich neointima through 5-hydroxytryptamine2A receptor in rabbit femoral arteries |
| Q37250033 | Serotonin uptake rates in platelets from angiotensin II-induced hypertensive mice |
| Q27022328 | Serotonin: a different player in hypertension-associated thrombosis |
| Q42913768 | Suppression of high lipid diet induced by atherosclerosis sarpogrelate |
| Q42574744 | Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. |
| Q90544035 | The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity |
| Q28539110 | The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function |
| Q34156166 | Upregulation of 5-hydroxytryptamine receptor signaling in coronary arteries after organ culture |